The price of abandoning diagnostic testing for cell-free fetal DNA screening

Prenat Diagn. 2018 Mar;38(4):243-245. doi: 10.1002/pd.5226. Epub 2018 Feb 21.

Authors

Mark I Evans^{1

2

3}, Shara M Evans^{2

3}, Terry Ann Bennett⁴, Ronald J Wapner⁵

Affiliations

¹ Department of Obstetrics and Gynecology, Mt Sinai School of Medicine, New York, NY, USA.
² Fetal Medicine Foundation of America, New York, NY, USA.
³ Comprehensive Genetics, New York, NY, USA.
⁴ Department of Obstetrics and Gynecology, Tisch Medical School, New York University, New York, NY, USA.
⁵ Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA.

PMID: 29417598
DOI: 10.1002/pd.5226

No abstract available

Publication types

Editorial

MeSH terms

Cell-Free Nucleic Acids / analysis*
Female
Fetal Diseases / diagnosis*
Fetal Diseases / economics
Humans
Models, Economic*
Pregnancy
Prenatal Diagnosis / economics*
Prenatal Diagnosis / trends

Substances

Cell-Free Nucleic Acids